| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 259, Issue 19, 11763-11770, Oct, 1984
JE Koda and M Bernfield
Mouse mammary epithelial cells (NMuMG cells) deposit at their basal surfaces an extracellular heparan sulfate-rich proteoglycan that binds to type I collagen. The binding of the purified proteoglycan to collagen was studied by (i) a solid phase assay, (ii) a suspension assay using preformed collagen fibrils, and (iii) a collagen fibril affinity column. The binding interaction occurs at physiological pH and ionic strength and can be inhibited only by salt concentrations that greatly exceed those found physiologically. Binding requires the intact proteoglycan since the protein-free glycosaminoglycan chains will not bind under the conditions of these assays. However, binding is mediated through the heparan sulfate chains as it can be inhibited by block- sulfated polysaccharides, including heparin. Binding requires native collagen structure which may be optimal when the collagen is in a fibrillar configuration. Binding sites on collagen fibrils are saturable, high affinity (Kd approximately 10(-10) M), and selective for heparin-like glycosaminoglycans. Because a culture substratum of type I collagen fibrils causes NMuMG cells to accumulate heparan sulfate proteoglycan into a basal lamina-like layer, binding of heparan sulfate proteoglycans to type I collagen may lead to the formation of a basal lamina and may link the basal lamina to the connective tissue matrix, an association found in basement membranes.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Kataropoulou, C. Henderson, and H. Grant The influence of glycosaminoglycans and crosslinking agents on the phenotype of hepatocytes cultured on collagen gels Human and Experimental Toxicology, February 1, 2003; 22(2): 65 - 71. [Abstract] [PDF]
|
|
|
|
 |
|
 G. A. Di Lullo, S. M. Sweeney, J. Korkko, L. Ala-Kokko, and J. D. San Antonio Mapping the Ligand-binding Sites and Disease-associated Mutations on the Most Abundant Protein in the Human, Type I Collagen J. Biol. Chem., February 1, 2002; 277(6): 4223 - 4231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Romaris, C. Coomans, H. Ceulemans, A.-M. Bruystens, S. Vekemans, and G. David Molecular Polymorphism of the Syndecans. IDENTIFICATION OF A HYPO-GLYCANATED MURINE SYNDECAN-1 SPLICE VARIANT J. Biol. Chem., June 25, 1999; 274(26): 18667 - 18674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Koyama, M. G. Kinsella, T. N. Wight, U. Hedin, and A. W. Clowes Heparan Sulfate Proteoglycans Mediate a Potent Inhibitory Signal for Migration of Vascular Smooth Muscle Cells Circ. Res., August 10, 1998; 83(3): 305 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. J. Edwards, H. Xu, J. C. Obunike, I. J. Goldberg, and W. D. Wagner Differentiated Macrophages Synthesize a Heparan Sulfate Proteoglycan and an Oversulfated Chondroitin Sulfate Proteoglycan That Bind Lipoprotein Lipase Arterioscler. Thromb. Vasc. Biol., March 1, 1995; 15(3): 400 - 409. [Abstract] [Full Text]
|
|
|
|
 |
|
 M Yamagata, S Saga, M Kato, M Bernfield, and K Kimata Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts. Implications for their roles in cell-substratum adhesion J. Cell Sci., January 9, 1993; 106(1): 55 - 65. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
